MétaCan
Menu
Back to cohort
Record W4402477198 · doi:10.2967/jnumed.124.267982

Dual Somatostatin Receptor/<sup>18</sup>F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors

2024· article· en· W4402477198 on OpenAlexaff
Ur Metser, Jose E. Nuñez, David Chan, Roshini Kulanthaivelu, Vanessa Murad, Anna Santiago, Simron Singh

Bibliographic record

VenueJournal of Nuclear Medicine · 2024
Typearticle
Languageen
FieldMedicine
TopicNeuroendocrine Tumor Research Advances
Canadian institutionsUniversity Health NetworkSunnybrook Health Science CentreWomen's College Hospital
Fundersnot available
KeywordsSomatostatin receptorNeuroendocrine tumorsSomatostatinPositron emission tomographyMedicineNuclear medicineInternal medicine

Abstract

fetched live from OpenAlex

Our purpose was to prospectively assess the distribution of NETPET scores in well-differentiated (WD) grade 2 and 3 gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) and to determine the impact of the NETPET score on clinical management. <b>Methods:</b> This single-arm, institutional ethics review board–approved prospective study included 40 patients with histologically proven WD GEP NETs. <sup>68</sup>Ga-DOTATATE PET and <sup>18</sup>F-FDG PET were performed within 21 d of each other. NETPET scores were evaluated qualitatively by 2 reviewers, with up to 10 marker lesions selected for each patient. The quantitative parameters that were evaluated included marker lesion SUV<sub>max</sub> for each tracer; <sup>18</sup>F-FDG/<sup>68</sup>Ga-DOTATATE SUV<sub>max</sub> ratios; functional tumor volume (FTV) and metabolic tumor volume (MTV) on <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET, respectively; and FTV/MTV ratios. The treatment plan before and after <sup>18</sup>F-FDG PET was recorded. <b>Results:</b> There were 22 men and 18 women (mean age, 60.8 y) with grade 2 (<i>n</i> = 24) or grade 3 (<i>n</i> = 16) tumors and a mean Ki-67 index of 16.1%. NETPET scores of P0, P1, P2A, P2B, P3B, P4B, and P5 were documented in 2 (5%), 5 (12.5%), 5 (12.5%) 20 (50%), 2 (5%), 4 (10%), and 2 (5%) patients, respectively. No association was found between the SUV<sub>max</sub> of target lesions on <sup>68</sup>Ga-DOTATATE and the SUV<sub>max</sub> of target lesions on <sup>18</sup>F-FDG PET (<i>P</i> = 0.505). <sup>18</sup>F-FDG/<sup>68</sup>Ga-DOTATATE SUV<sub>max</sub> ratios were significantly lower for patients with low (P1–P2) primary NETPET scores than for those with high (P3–P5) primary NETPET scores (mean ± SD, 0.20 ± 0.13 and 1.68 ± 1.44, respectively; <i>P</i> &lt; 0.001). MTV on <sup>18</sup>F-FDG PET was significantly lower for low primary NETPET scores than for high ones (mean ± SD, 464 ± 601 cm<sup>3</sup> and 66 ± 114 cm<sup>3</sup>, respectively; <i>P</i> = 0.005). A change in the type of management was observed in 42.5% of patients after <sup>18</sup>F-FDG PET, with the most common being a change from systemic therapy to peptide receptor radionuclide therapy and from debulking surgery to systemic therapy. <b>Conclusion:</b> There was a heterogeneous distribution of NETPET scores in patients with WD grade 2 and 3 GEP NETs, with more than 1 in 5 patients having a high NETPET score and a frequent change in management after <sup>18</sup>F-FDG PET. Quantitative parameters including <sup>18</sup>F-FDG/<sup>68</sup>Ga-DOTATATE SUV<sub>max</sub> ratios in target lesions and FTV/MTV ratios can discriminate between patients with high and low NETPET scores.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.117
Threshold uncertainty score0.980

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.269
Teacher spread0.260 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations13
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Nuclear MedicineSame topicNeuroendocrine Tumor Research AdvancesFrench-language works237,207